Since intranasal delivery of anticonvulsive drugs has been postulated in epilepsy and to treat neurodegenerative diseases, an anti-CD40L antibody (see methods) was administered intranasally before seizure induction using PTZ30–32. This evidence concerns the gene CD40LG and neurodegenerative disease.